S. Süsser

2.2k total citations
61 papers, 1.7k citations indexed

About

S. Süsser is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, S. Süsser has authored 61 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Hepatology, 33 papers in Epidemiology and 19 papers in Infectious Diseases. Recurrent topics in S. Süsser's work include Hepatitis C virus research (55 papers), Hepatitis B Virus Studies (28 papers) and HIV/AIDS drug development and treatment (18 papers). S. Süsser is often cited by papers focused on Hepatitis C virus research (55 papers), Hepatitis B Virus Studies (28 papers) and HIV/AIDS drug development and treatment (18 papers). S. Süsser collaborates with scholars based in Germany, United States and Italy. S. Süsser's co-authors include Christoph Sarrazin, Stefan Zeuzem, Eva Herrmann, Johannes Vermehren, D. Perner, Thomas Berg, Stefan Zeuzem, Christoph Welsch, Jörn Lötsch and U. Karey and has published in prestigious journals such as PLoS ONE, Hepatology and Journal of Virology.

In The Last Decade

S. Süsser

61 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Süsser Germany	21	1.4k	1.2k	448	278	171	61	1.7k
Mani Subramanian United States	17	756 0.6×	780 0.7×	206 0.5×	210 0.8×	49 0.3×	62	1.1k
Tomoyoshi Ohno Japan	23	1.2k 0.9×	1.2k 1.0×	312 0.7×	116 0.4×	30 0.2×	50	1.6k
D C Wong United States	14	973 0.7×	895 0.8×	180 0.4×	181 0.7×	55 0.3×	22	1.3k
Jane Fang United States	19	755 0.6×	740 0.6×	114 0.3×	282 1.0×	44 0.3×	35	1.3k
Yasuhiro Itsui Japan	20	920 0.7×	734 0.6×	157 0.4×	378 1.4×	41 0.2×	53	1.5k
Hideharu Harada Japan	13	1.3k 1.0×	984 0.8×	157 0.4×	260 0.9×	50 0.3×	26	1.6k
Tanja B. Jensen Denmark	15	1.2k 0.9×	1.1k 0.9×	138 0.3×	174 0.6×	73 0.4×	18	1.3k
Michelle Martinot-Peignoux France	22	2.4k 1.7×	2.4k 2.0×	158 0.4×	128 0.5×	66 0.4×	54	2.6k
Eric G. Meissner United States	21	666 0.5×	629 0.5×	225 0.5×	216 0.8×	50 0.3×	69	1.3k
Isla Humphreys United Kingdom	8	1.4k 1.1×	1.3k 1.1×	266 0.6×	132 0.5×	19 0.1×	11	1.6k

Countries citing papers authored by S. Süsser

Since Specialization

Citations

This map shows the geographic impact of S. Süsser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Süsser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Süsser more than expected).

Fields of papers citing papers by S. Süsser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Süsser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Süsser. The network helps show where S. Süsser may publish in the future.

Co-authorship network of co-authors of S. Süsser

This figure shows the co-authorship network connecting the top 25 collaborators of S. Süsser. A scholar is included among the top collaborators of S. Süsser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Süsser. S. Süsser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Peiffer, Kai‐Henrik, Johannes Vermehren, S. Süsser, et al.. (2018). Interferon-free treatment choice according to baseline RASs leads to high SVR rates in HCV genotype 1 infected patients. Journal of Infection and Chemotherapy. 24(7). 524–530. 5 indexed citations

Jiang, Bingfu, Alica Kubesch, Johannes Vermehren, et al.. (2018). Impact of HBV genotype and mutations on HBV DNA and qHBsAg levels in patients with HBeAg‐negative chronic HBV infection. Alimentary Pharmacology & Therapeutics. 47(11). 1523–1535. 23 indexed citations

Mangia, Alessandra, S. Süsser, Valeria Piazzolla, et al.. (2016). Sofosbuvir and ribavirin for genotype 2 HCV infected patients with cirrhosis: A real life experience. Journal of Hepatology. 66(4). 711–717. 19 indexed citations

Penna-Martinez, Marissa, D. Perner, S. Süsser, et al.. (2016). IL28B gene variants and glucose metabolism in Type 2 Diabetes. Human Immunology. 77(12). 1280–1283. 4 indexed citations

Fevery, Bart, S. Süsser, Oliver Lenz, et al.. (2015). Comparison of three quantitative HCV RNA assays in samples from HCV genotype 1- or 4-infected patients treated with the NS3/4A protease inhibitor simeprevir. Journal of Clinical Virology. 72. 133–140. 8 indexed citations

Dietz, Julia, et al.. (2015). Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients. PLoS ONE. 10(8). e0134395–e0134395. 61 indexed citations

Dietz, Julia, Daniel Rupp, D. Perner, et al.. (2015). P0818 : Analysis of NS3 protease resistance-associated variants and phenotypes for the prediction of treatment response to HCV triple therapy. Journal of Hepatology. 62. S643–S643. 1 indexed citations

Vermehren, Johannes, Alessio Aghemo, Karolin Falconer, et al.. (2014). Clinical significance of residual viremia detected by two real-time PCR assays for response-guided therapy of HCV genotype 1 infection. Journal of Hepatology. 60(5). 913–919. 34 indexed citations

Maasoumy, Benjamin, Béla Hunyady, Vincenza Calvaruso, et al.. (2014). Performance of Two HCV RNA Assays during Protease Inhibitor-Based Triple Therapy in Patients with Advanced Liver Fibrosis and Cirrhosis. PLoS ONE. 9(11). e110857–e110857. 13 indexed citations

10.

Welsch, Christoph, Jérôme Gouttenoire, Markus Schneider, et al.. (2014). Hepatitis C virus variants resistant to macrocyclic NS3-4A inhibitors subvert IFN-β induction by efficient MAVS cleavage. Journal of Hepatology. 62(4). 779–784. 12 indexed citations

11.

Süsser, S., Eva Herrmann, Christian M. Lange, et al.. (2014). Predictive Value of Interferon-Lambda Gene Polymorphisms for Treatment Response in Chronic Hepatitis C. PLoS ONE. 9(11). e112592–e112592. 18 indexed citations

12.

Vermehren, Johannes, Alessio Aghemo, Kai‐Henrik Peiffer, et al.. (2013). 506 UNDETECTABLE HCV-RNA IN TELAPREVIR-TREATED PATIENTS: LOW CONCORDANCE BETWEEN TWO HIGHLY SENSITIVE REAL-TIME PCR ASSAYS. Journal of Hepatology. 58. S208–S208. 2 indexed citations

13.

Fischer, Janett, Stephan Böhm, Tobias Müller, et al.. (2013). Association of IFNL3 rs12979860 and rs8099917 with Biochemical Predictors of Interferon Responsiveness in Chronic Hepatitis C Virus Infection. PLoS ONE. 8(10). e77530–e77530. 5 indexed citations

14.

Welker, Martin, S. Süsser, Christoph Welsch, et al.. (2012). Modulation of replication efficacy of the hepatitis C virus replicon Con1 by site‐directed mutagenesis of an NS4B aminoterminal basic leucine zipper. Journal of Viral Hepatitis. 19(11). 775–783. 4 indexed citations

15.

Fischer, Janett, Stephan Böhm, Markus Scholz, et al.. (2012). Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection. Hepatology. 55(6). 1700–1710. 66 indexed citations

16.

Vermehren, Johannes, S. Süsser, Christian M. Lange, et al.. (2011). Mutations selected in the hepatitis C virus NS3 protease domain during sequential treatment with boceprevir with and without pegylated interferon alfa‐2b. Journal of Viral Hepatitis. 19(2). 120–127. 39 indexed citations

17.

Süsser, S., Johannes Vermehren, Nicole Forestier, et al.. (2011). Analysis of long-term persistence of resistance mutations within the hepatitis C virus NS3 protease after treatment with telaprevir or boceprevir. Journal of Clinical Virology. 52(4). 321–327. 87 indexed citations

18.

Lange, Christian M., S. Süsser, Eva Herrmann, et al.. (2011). HVR-1 heterogeneity during treatment with telaprevir with or without pegylated interferon alfa-2a. Scandinavian Journal of Gastroenterology. 46(11). 1362–1368. 2 indexed citations

19.

Sarrazin, Christoph, S. Süsser, Alexandra Doehring, et al.. (2010). Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients. Journal of Hepatology. 54(3). 415–421. 191 indexed citations

20.

Süsser, S., Christoph Welsch, Yalan Wang, et al.. (2009). Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus–infected patients†. Hepatology. 50(6). 1709–1718. 252 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact